Keywords: prostrakan, submits, sancuso, maa, galashiels, scotland-based, submitted
ProStrakan submits Sancuso MAA
Article | 23 July 2007
Galashiels, Scotland-based ProStrakan has submitted a Marketing Authorization Application to the European pharmaceutical regulator for Sancuso, its transdermal granisetron patch ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
